Impulse control disorder and rapid eye movement sleep behavior disorder in Parkinson's disease.

Bayard S, Dauvilliers Y, Yu H, Croisier-Langenier M, Rossignol A, Charif M, Geny C, Carlander B, Cochen De Cock V.

Parkinsonism Relat Disord. 2014 Dec;20(12):1411-4. doi: 10.1016/j.parkreldis.2014.09.020.

Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy.

Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M.

Eur J Radiol. 2014 Mar;83(3):564-70. doi: 10.1016/j.ejrad.2013.11.024.

Methods for Surgical Targeting of the STN in Early-Stage Parkinson's Disease.

Camalier CR, Konrad PE, Gill CE, Kao C, Remple MR, Nasr HM, Davis TL, Hedera P, Phibbs FT, Molinari AL, Neimat JS, Charles D.

Front Neurol. 2014 Mar 19;5:25. doi: 10.3389/fneur.2014.00025.

Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.

Morin N, Di Paolo T.

Int Rev Neurobiol. 2014;119:151-67. doi: 10.1016/B978-0-12-801022-8.00007-6.

Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.

Proukakis C, Shoaee M, Morris J, Brier T, Kara E, Sheerin UM, Charlesworth G, Tolosa E, Houlden H, Wood NW, Schapira AH.

Mov Disord. 2014 Jul;29(8):1060-4. doi: 10.1002/mds.25883.

The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease.

Conson M, Trojano L, Vitale C, Mazzarella E, Allocca R, Barone P, Grossi D, Santangelo G.

Hum Mov Sci. 2014 Feb;33:343-53. doi: 10.1016/j.humov.2013.10.006.

King David, son of Jesse: the world's first Parkinson's patient ...observations from November 2013.

Voyles CR.

J Miss State Med Assoc. 2014 Jan;55(1):14-5, 17-8. No abstract available.

Zolpidem and the risk of Parkinson's disease: a nationwide population-based study.

Yang YW, Hsieh TF, Yu CH, Huang YS, Lee CC, Tsai TH.

J Psychiatr Res. 2014 Nov;58:84-8. doi: 10.1016/j.jpsychires.2014.07.003.

Prevalence of malnutrition in patients with Parkinson's disease: a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire.

Fereshtehnejad SM, Ghazi L, Sadeghi M, Khaefpanah D, Shahidi GA, Delbari A, Lökk J.

J Parkinsons Dis. 2014;4(3):473-81. doi: 10.3233/JPD-130323.

Team nurse does its bit for Parkinson's UK.

[No authors listed]

Nurs Stand. 2014 Sep 23;29(3):11. doi: 10.7748/ns.29.3.11.s12.

Triggering receptor expressed on myeloid cells 2 variants are rare in Parkinson's disease in a Han Chinese cohort.

Feng SJ, Nie K, Gan R, Huang J, Zhang YW, Wang LM, Zhao JH, Tang HM, Gao L, Zhu RM, Duan ZP, Zhang YH, Wang LJ.

Neurobiol Aging. 2014 Jul;35(7):1780.e11-2. doi: 10.1016/j.neurobiolaging.2014.01.142.

Copper pathology in vulnerable brain regions in Parkinson's disease.

Davies KM, Bohic S, Carmona A, Ortega R, Cottam V, Hare DJ, Finberg JP, Reyes S, Halliday GM, Mercer JF, Double KL.

Neurobiol Aging. 2014 Apr;35(4):858-66. doi: 10.1016/j.neurobiolaging.2013.09.034.

Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis.

Sun YX, Wang XH, Xu AH, Zhao JH.

J Neurol Sci. 2014 Oct 15;345(1-2):97-105. doi: 10.1016/j.jns.2014.07.016.

Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China.

Wu Y, Guo XY, Wei QQ, Song W, Chen K, Cao B, Ou RW, Zhao B, Shang HF.

J Neurol Sci. 2014 May 15;340(1-2):144-9. doi: 10.1016/j.jns.2014.03.014.

Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.

Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC.

Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. doi: 10.1016/j.parkreldis.2014.08.002.